Patents Assigned to SAGANATURA EHF.
  • Method for enhancing beta-adrenergic response
    Patent number: 11850257
    Abstract: The present invention provides cnidimoside A for use in the treatment of urinary conditions such as overactive bladder and related syndromes. The invention also relates to methods of treatment of overactive bladder using cnidimoside A. The compound can be administered purified or as a plant extract.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: December 26, 2023
    Assignee: SAGANATURA EHF.
    Inventor: Steinthor Sigurdsson